IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

International Biotechnology Trust PLC

Q3 2018 Holdings

Filed 2018-11-13 | 51 holdings | $210.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2018-11-14) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)ACOM09061G101$7.2K97,2843.4%
Ligand Pharmaceuticals Inc(LGND)ACOM53220K504$7.4K35,0003.5%
Stemline Therapeutics Inc(RIGLUSD)COM766559603$7.5K585,9303.5%
Stemline Therapeutics IncACOM85858C107$7.5K585,9303.5%
Alexion Pharmaceuticals Inc(ALXN)ACOM015351109$8.7K81,6414.1%
Exelixis Inc(EXEL)ACOM30161Q104$9.6K704,5344.6%
Regeneron Pharmaceuticals(REGN)ACOM75886F107$9.7K31,3304.6%
Regeneron PharmaceuticalsCOM608550109$9.7K31,3304.6%
Array Biopharma Inc(ARRYEUR)COM04269X105$9.8K844,5004.7%
Vertex Pharmaceuticals Inc(VRTX)ACOM92532F100$10.0K67,7224.8%
Incyte Corp(INCY)ACOM45337C102$10.6K200,0005.0%
Illumina Inc(ILMN)ACOM452327109$14.5K51,6006.9%
Celgene Corp(CELG)ACOM151020104$17.4K253,5228.3%
Celgene Corp(ONC)COM07725L102$17.4K253,5228.3%
PreviousPage 2 of 2